Works in Cancer Chemotherapy & Pharmacology, 2013, Vol 71, Issue 1

Results: 31

Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 153, doi. 10.1007/s00280-012-1992-x

By:

Litviakov, Nicolay;
Cherdyntseva, Nadezhda;
Tsyganov, Matvey;
Denisov, Evgeny;
Garbukov, Evgeny;
Merzliakova, Marina;
Volkomorov, Victor;
Vtorushin, Sergey;
Zavyalova, Marina;
Slonimskaya, Elena;
Perelmuter, Vladimir

Publication type:

Article

Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 29, doi. 10.1007/s00280-012-2023-7

By:

Kusaba, Hitoshi;
Esaki, Taito;
Kishimoto, Junji;
Uchino, Keita;
Arita, Shuji;
Kumagai, Hozumi;
Mitsugi, Kenji;
Akashi, Koichi;
Baba, Eishi

Publication type:

Article

Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 183, doi. 10.1007/s00280-012-1995-7

By:

Ott, Patrick;
Chang, Jason;
Madden, Kathleen;
Kannan, Rajni;
Muren, Caroline;
Escano, Crystal;
Cheng, Xin;
Shao, Yongzhao;
Mendoza, Sandra;
Gandhi, Alex;
Liebes, Leonard;
Pavlick, Anna

Publication type:

Article

Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 53, doi. 10.1007/s00280-012-1972-1

By:

Kerklaan, Bojana;
Diéras, Veronique;
Tourneau, Christophe;
Mergui-Roelvink, Marja;
Huitema, Alwin;
Rosing, Hilde;
Beijnen, Jos;
Marreaud, Sandrine;
Govaerts, Anne-Sophie;
Piccart-Gebhart, Martine;
Schellens, Jan;
Awada, Ahmad

Publication type:

Article

Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 85, doi. 10.1007/s00280-012-1981-0

By:

Takahara, Naminatsu;
Nakai, Yousuke;
Isayama, Hiroyuki;
Sasaki, Takashi;
Satoh, Yumiko;
Takai, Daiya;
Hamada, Tsuyoshi;
Uchino, Rie;
Mizuno, Suguru;
Miyabayashi, Koji;
Mohri, Dai;
Kawakubo, Kazumichi;
Kogure, Hirofumi;
Yamamoto, Natsuyo;
Sasahira, Naoki;
Hirano, Kenji;
Ijichi, Hideaki;
Tada, Minoru;
Yatomi, Yutaka;
Koike, Kazuhiko

Publication type:

Article

Phase I study of 5-aza-2'-deoxycytidine in combination with valproic acid in non-small-cell lung cancer.

Published in:

2013

By:

Chu BF;
Karpenko MJ;
Liu Z;
Aimiuwu J;
Villalona-Calero MA;
Chan KK;
Grever MR;
Otterson GA;
Chu, B F;
Karpenko, M J;
Liu, Z;
Aimiuwu, J;
Villalona-Calero, M A;
Chan, K K;
Grever, M R;
Otterson, G A

Publication type:

journal article

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 245, doi. 10.1007/s00280-012-2002-z

By:

Pliarchopoulou, K.;
Kalogeras, K.;
Kronenwett, R.;
Wirtz, R.;
Eleftheraki, A.;
Batistatou, A.;
Bobos, M.;
Soupos, N.;
Polychronidou, G.;
Gogas, H.;
Samantas, E.;
Christodoulou, C.;
Makatsoris, T.;
Pavlidis, N.;
Pectasides, D.;
Fountzilas, G.

Publication type:

Article

PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenografts.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 133, doi. 10.1007/s00280-012-1988-6

By:

Choo, Edna;
Ng, Chee;
Berry, Leanne;
Belvin, Marcia;
Lewin-Koh, Nicholas;
Merchant, Mark;
Salphati, Laurent

Publication type:

Article

Pharmacokinetic-pharmacodynamic relationship of bosutinib in patients with chronic phase chronic myeloid leukemia.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 209, doi. 10.1007/s00280-012-1998-4

By:

Hsyu, Poe-Hirr;
Mould, Diane;
Upton, Richard;
Amantea, Michael

Publication type:

Article

Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 219, doi. 10.1007/s00280-012-1999-3

By:

Yin, Ophelia;
Bédoucha, Véronique;
McCulloch, Tracey;
Zheng, Cheng;
Zhou, Wei;
Hussaini, Azra;
Novick, Steven

Publication type:

Article

Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 103, doi. 10.1007/s00280-012-1983-y

By:

Zhang, Jian;
Gu, Shi-Yang;
Gan, Yu;
Wang, Zhong-Hua;
Wang, Bi-Yun;
Guo, Hai-Yi;
Wang, Jia-Lei;
Wang, Lei-Ping;
Zhao, Xin-Min;
Hu, Xi-Chun

Publication type:

Article

Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 63, doi. 10.1007/s00280-012-1977-9

By:

Esteva, Francisco;
Moulder, Stacy;
Gonzalez-Angulo, Ana;
Ensor, Joe;
Murray, James;
Green, Marjorie;
Koenig, Kimberly;
Lee, Mong-Hong;
Hortobagyi, Gabriel;
Yeung, Sai-Ching

Publication type:

Article

Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 165, doi. 10.1007/s00280-012-1993-9

By:

Park, Mi;
Kim, Seung;
Park, Jun;
Kim, Do;
Ahn, Sang;
Han, Kwang;
Chon, Chae;
Seong, Jinsil

Publication type:

Article

Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 43, doi. 10.1007/s00280-012-1970-3

By:

Kang, Yoon-Koo;
Kang, Byung;
Im, Seock-Ah;
Lee, Jae-Lyun;
Park, Sook;
Kang, Won;
Chang, Heung;
Kim, Tae;
Oh, Do-Youn;
Jung, Kyung;
Ryu, Min-Hee

Publication type:

Article

Association between KRAS codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 265, doi. 10.1007/s00280-012-2005-9

By:

Chen, Jian;
Ye, Yun;
Sun, Haozhen;
Shi, Genming

Publication type:

Article

Evaluation of the pharmacokinetics and safety of bosutinib in patients with chronic hepatic impairment and matched healthy subjects.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 123, doi. 10.1007/s00280-012-1987-7

By:

Abbas, Richat;
Chalon, Stephan;
Leister, Cathie;
Gaaloul, Myriam;
Sonnichsen, Daryl

Publication type:

Article

Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 175, doi. 10.1007/s00280-012-1994-8

By:

Miyahara, T.;
Mochinaga, S.;
Kimura, S.;
Aragane, N.;
Yakabe, T.;
Morita, S.;
Okudaira, K.;
Fujito, H.

Publication type:

Article

Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 227, doi. 10.1007/s00280-012-2000-1

By:

Doi, Toshihiko;
Ohtsu, Atsushi;
Fuse, Nozomu;
Yoshino, Takayuki;
Tahara, Makoto;
Shibayama, Kazuhiro;
Takubo, Takatoshi;
Weinreich, David

Publication type:

Article

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 21, doi. 10.1007/s00280-012-1917-8

By:

Gordon, Michael;
Ilaria, Robert;
Alwis, Dinesh;
Mendelson, David;
McKane, Scott;
Wagner, Margaret;
Look, Katherine;
LoRusso, Patricia

Publication type:

Article

XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 257, doi. 10.1007/s00280-012-2004-x

By:

Rosati, Gerardo;
Avallone, Antonio;
Aprile, Giuseppe;
Butera, Alfredo;
Reggiardo, Giorgio;
Bilancia, Domenico

Publication type:

Article

Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 193, doi. 10.1007/s00280-012-1996-6

By:

LoRusso, Patricia;
Piha-Paul, Sarina;
Mita, Monica;
Colevas, A.;
Malhi, Vikram;
Colburn, Dawn;
Yin, Ming;
Low, Jennifer;
Graham, Richard

Publication type:

Article

Phase I study of 5-aza-2′-deoxycytidine in combination with valproic acid in non-small-cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 115, doi. 10.1007/s00280-012-1986-8

By:

Chu, B.;
Karpenko, M.;
Liu, Z.;
Aimiuwu, J.;
Villalona-Calero, M.;
Chan, K.;
Grever, M.;
Otterson, G.

Publication type:

Article

A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 93, doi. 10.1007/s00280-012-1982-z

By:

Plummer, Ruth;
Madi, Ayman;
Jeffels, Melinda;
Richly, Heike;
Nokay, Bahar;
Rubin, Stephen;
Ball, Howard;
Weller, Steve;
Botbyl, Jeffrey;
Gibson, Diana;
Scheulen, Max

Publication type:

Article

Erlotinib in patients with advanced lung squamous cell carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 203, doi. 10.1007/s00280-012-1997-5

By:

Chiang, Chi-Lu;
Tsai, Chun-Ming;
Chou, Teh-Ying;
Chen, Yuh-Min;
Lai, Shinn-Liang;
Shih, Jen-Fu;
Chiu, Chao-Hua;
Lee, Yu-Chin

Publication type:

Article

Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 237, doi. 10.1007/s00280-012-2001-0

By:

Chi, K.;
Tolcher, A.;
Lee, P.;
Rosen, P.;
Kollmannsberger, C.;
Papadopoulos, K.;
Patnaik, A.;
Molina, A.;
Jiao, J.;
Pankras, C.;
Kaiser, B.;
Bernard, A.;
Tran, N.;
Acharya, M.

Publication type:

Article

Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 13, doi. 10.1007/s00280-012-1984-x

By:

Kartal Yandım, Melis;
Apohan, Elif;
Baran, Yusuf

Publication type:

Article

Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 73, doi. 10.1007/s00280-012-1980-1

By:

Parise, Robert;
Anyang, Bean;
Eiseman, Julie;
Egorin, Merrill;
Covey, Joseph;
Beumer, Jan

Publication type:

Article

Assessing the in vivo efficacy of biologic antiangiogenic therapies.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 1, doi. 10.1007/s00280-012-1978-8

By:

Wilson, Peter;
LaBonte, Melissa;
Lenz, Heinz-Josef

Publication type:

Article

Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 145, doi. 10.1007/s00280-012-1991-y

By:

Cui, Yuehong;
Li, Qian;
Yu, Yiyi;
Chen, Yong;
Feng, Yi;
Wang, Yan;
Liu, Tianshu

Publication type:

Article

Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 35, doi. 10.1007/s00280-012-1963-2

By:

Nemunaitis, John;
Mita, Alain;
Stephenson, Joe;
Mita, Monica;
Sarantopoulos, John;
Padmanabhan-Iyer, Swami;
Nanda, Nisha;
Gleich, Lyon;
Benichou, Annie-Claude;
Craig, Adam

Publication type:

Article

Hemodialysis no reason to withhold everolimus.

Published in:

2013

By:

Rooijen, J.;
Vries, E.

Publication type:

Letter